Richard I Steinhart
CIK 1293789 · Chief Financial Officer · last filed 2026-06-17
Richard I Steinhart is a Chief Financial Officer who has filed 74 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for BTAI, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$350.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $46.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$46.7K
5
74
-$350.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BTAI | Chief Financial Officer | 26,335 | $0.84 | $22.3K | -$364.6K | 32 | 2026-06-17 |
| ATOS | Director | 10,000 | $2.42 | $24.1K | $0 | 13 | 2026-05-14 |
| ATNM | Director | 317 | $0.87 | $275 | $5.0K | 11 | 2025-04-02 |
| STRATA Skin Sciences, Inc. (MELA) Delisted | Chief Financial Officer | 25,000 | — | — | $8.7K | 6 | 2013-08-08 |
| TG THERAPEUTICS, INC. (MHA) Delisted | Director | 5,633 | — | — | $0 | 1 | 2007-01-31 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | BTAI | Exer (M) | +35 | $0 | EDGAR |
| 2026-05-22 | BTAI | Mixed | +10,655 | -$7.4K | EDGAR |
| 2026-05-20 | BTAI | Notice (144) | −6,845 | -$7.4K | EDGAR |
| 2026-05-14 | ATOS | Grant (A) | +10,000 | $0 | EDGAR |
| 2026-05-07 | BTAI | Exer (M) | +9,000 | $0 | EDGAR |
| 2026-03-16 | BTAI | Exer (M) | +68 | $0 | EDGAR |
| 2026-01-05 | BTAI | Grant (A) | — | $0 | EDGAR |
| 2025-12-15 | BTAI | Exer (M) | +68 | $0 | EDGAR |
| 2025-09-16 | BTAI | Exer (M) | +68 | $0 | EDGAR |
| 2025-08-05 | BTAI | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.